Rare Cancers Australia Ltd (ABN 24 159 196 997) (RCA) endorses and supports the delivery of international best clinical practice including access to therapeutics and medicines by members of societies and professions, to benefit patient management.
The information in this portal with regard to Medicines Access Programs is the responsibility of and has been entered into by each participating Pharmaceutical Company. RCA (or any party associated with RCA and/or the development of this portal) does not warrant or represent that the information is accurate, current, free from errors or omissions.
The information and data in this portal are intended solely for Australian Health Practitioner Regulation Agency (AHPRA)-registered medical practitioners and pharmacists.
The use of the information and data contained in this portal is at the sole risk and based on the clinical discretion of qualified members of the AHPRA-registered healthcare professionals as noted above. Medical practitioners and pharmacists using the information and data are responsible for ensuring by independent verification, its accuracy, currency or completeness.
The information provided should not be regarded as a substitute for detailed expert advice on individual patients or clinical cases. RCA will accept no responsibility for any loss, claim or damage suffered or caused by any person acting or refraining from action as a result of any material in this portal.
Information presented in this portal is the copyright of RCA or the participating Pharmaceutical Companies. Apart from any use as permitted under the Copyright Act 1968 or as otherwise permitted under the Terms and Conditions, no part of this information may be reproduced without written permission.
Last Updated June 01, 2023.
You are about to edit a program. This will need to be approved by MAP admin before changes are visible to clinicians.
Do you want to continue?
Update program
Optional details about the drug and/or program
All fields are optional
Update program
Company contact details
The Therapeutic Goods Act prohibits the promotion of unregistered products. Users should not include any brand names or any promotional attributes in the program information provided. Inclusion of therapy area and generic name is accepted.
Fields marked * are required
Update program
NON-TGA approved indication - Program details
The Therapeutic Goods Act prohibits the promotion of unregistered products. Users should not include any brand names or any promotional attributes in the program information provided. Inclusion of therapy area and generic name is accepted.
Fields marked * are required
Update program
Optional details about the drug and/or program
All fields are optional
Update program
Company contact details
Fields marked * are required
Update program
TGA registered prescription medicine for a TGA registered indication
Fields marked * are required
Profile reset password
Minimum length of 8 characters.
Uppercase letter
Lowercase letter
Number
Contains a special character e.g. !, @, $, *
Your access has been suspended, please contact the MAP Administrator at map@rarecancers.org.au for support.
Your email has been verified.
Sorry, your account has been denied. Please contact the MAP administrator - map@rarecancers.org.au to obtain access.
Unfortunately we were unable to verify you as a representative of a company with permission to use the Medicines Access Portal.
You will receive an email on how to gain access.
Thank you . We were able to verify that your company is approved for access to the MAP website. An email has been sent to your registered company email address. Please check your SPAM box.
Reset new password
Minimum length of 8 characters.
Uppercase letter
Lowercase letter
Number
Contains a special character e.g. !, @, $, *
Reset password
Please accept the Terms of Use and Privacy Collection Statement.
All checkboxes must be selected.
All checkboxes must be selected.
Add a new program
Please indicate if:
Thank you. An email has been sent to you to verify your registered email address. Please check your SPAM box.
Rare Cancers Australia (RCA) and Medicines Australia (MA) advise that the information and data in the MAP are intended solely for AHPRA-registered Medical Practitioners and Pharmacists only.
I hereby confirm that in requesting to register to access the MAP
*Required field
*I work for a pharmaceutical company
Please agree to accept the Disclaimer, Privacy Policy and Terms and Conditions and tick all the relevant boxes.
The session has expired, please register again.
Registration
Please complete the form below and follow the prompt via email. Please note, the MAP is currently available to AHPRA-registered medical practitioners and pharmacists only.
* Required fields
Minimum length of 8 characters.
Uppercase letter
Lowercase letter
Number
Contains a special character e.g. !, @, $, *
Industry representative access form
Please provide the following details to validate your industry access to the MAP website.
Minimum length of 8 characters.
Uppercase letter
Lowercase letter
Number
Contains a special character e.g. !, @, $, *
*Required fields
Please confirm all of the above boxes have been selected.
Sign in
Registered members of the Medicines Access Portal please sign in. Need to register?
Add a new program
TGA registered prescription medicine for a TGA registered indication
Fields marked * are required
Program is available for:
Select country availability:
How long will the program be available for?
Is this program available for other non-TGA approved indications?
Select the disease(s) area for the program*
Required field incomplete – please enter disease state before progressing.
Is co-payment by the patient required?
Is this program capped for a finite number of patients?
Saved successfully.
Add a new program
Company contact details
Fields marked * are required
Saved successfully.
Add a new program
Optional details about the drug and/or program
All fields are optional
Saved successfully.
Add a new program
TGA registered prescription medicine for a NON-TGA registered indication
The Therapeutic Goods Act prohibits the promotion of unregistered products. Users should not include any brand names or any promotional attributes in the program information provided. Inclusion of therapy area and generic name is accepted.
Fields marked * are required
Program is available for:
Select the disease(s) area for the program*
Required field incomplete – please enter disease state before progressing.
Select country availability:
How long will the program be available for?
Is this program available for other non-TGA approved indications?
Is co-payment by the patient required?
Is this program capped for a finite number of patients?
Saved successfully.
Add a new program
Company contact details
The Therapeutic Goods Act prohibits the promotion of unregistered products. Users should not include any brand names or any promotional attributes in the program information provided. Inclusion of therapy area and generic name is accepted.
Fields marked * are required
Saved successfully.
Add a new program
Optional details about the drug and/or program
All fields are optional
Saved successfully.